Whereas CTGF, when bound to integrin β1, it activates the nuclear factor kappa-light-chain-enhancer of the activated B cells (NF-kB) signaling pathway which secretes additional growth factors, such as TGF-β, further facilitating glioblastoma invasiveness. Here, CCN2 is linked to glioblastoma.